共 186 条
[1]
Welsing PM(2001)The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis Arthritis Rheum 44 2009-2017
[2]
van Gestel AM(1999)Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time Arthritis Rheum 42 1854-1860
[3]
Swinkels HL(2006)Measuring function in rheumatoid arthritis: identifying reversible and irreversible components Arthritis Rheum 54 2784-2792
[4]
Kiemeney LA(2009)Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade Ann Rheum Dis 68 823-827
[5]
van Riel PL(2014)Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis Ann Rheum Dis 73 516-528
[6]
Drossaers-Bakker KW(2011)Adverse effects of biologics: a network meta-analysis and Cochrane overview Cochrane Database Syst Rev 2 CD008794-265
[7]
de Buck M(2015)Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis Lancet (London, England) 386 258-2285
[8]
van Zeben D(2006)Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 295 2275-565
[9]
Zwinderman AH(2015)De-intensifying treatment in established rheumatoid arthritis (RA): Why, how, when and in whom can DMARDs be tapered? Best Pract Res Clin Rheumatol 29 550-1642
[10]
Breedveld FC(2019)Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity Cochrane Database Syst Rev 5 CD010455-535